Opening the Blood-Brain Barrier and Improving the Efficacy of Temozolomide Treatments of Glioblastoma Using Pulsed, Focused Ultrasound with a Microbubble Contrast Agent

<table class="fixed-width table-group" id="tab1"><tr><td><table class="table"><colgroup><col style="width:4.42em"/><col style="width:13.64em"/><col style="width:3.77em"/></colgroup><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr class="thead"><td class="align_left">Group </td><td class="align_center">Mean GFAP level ± SD(<i>μ</i>g/ml) </td><td class="align_center"><i>P</i></td></tr><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr><td class="align_left">Control</td><td class="align_center">301.47 ± 7.85</td><td class="align_center" rowspan="2">&lt; 0.05</td></tr><tr><td class="align_left">Test</td><td class="align_center">472.78 ± 4.95</td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>ELISA-detected serum GFAP levels (means, n = 10).</div>

BioMed Research International

tab1

Table 1

Table 1: Opening the Blood-Brain Barrier and Improving the Efficacy of Temozolomide Treatments of Glioblastoma Using Pulsed, Focused Ultrasound with a Microbubble Contrast Agent 

Table 1 | Opening the Blood-Brain Barrier and Improving the Efficacy of Temozolomide Treatments of Glioblastoma Using Pulsed, Focused Ultrasound with a Microbubble Contrast Agent 